Risk factors involved in treatment delays and differences in treatment type for patients with prostate cancer by risk category in an academic safety net hospital.

Kan, Carolyn K; Qureshi, Muhammad M; Gupta, Apar; Agarwal, Ankit; Gignac, Gretchen A; Bloch, B Nicolas; Thoreson, Nicholas; Hirsch, Ariel E

Kan, Carolyn K; Qureshi, Muhammad M; Gupta, Apar; Agarwal, Ankit; Gignac, Gretchen A; Bloch, B Nicolas; Thoreson, Nicholas; Hirsch, Ariel E.

Afiliação

Kan CK; Department of Radiation Oncology, Boston University School of Medicine, Boston, Massachusetts.
Qureshi MM; Department of Radiation Oncology, Boston University School of Medicine, Boston, Massachusetts.
Gupta A; Rutgers R.W. Johnson University Hospital, New Brunswick, New Jersey.
Agarwal A; Department of Radiation Oncology, Boston University School of Medicine, Boston, Massachusetts.
Gignac GA; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Bloch BN; Department of Radiation Oncology, Boston University School of Medicine, Boston, Massachusetts.
Thoreson N; Department of Radiation Oncology, Boston University School of Medicine, Boston, Massachusetts.
Hirsch AE; Department of Radiation Oncology, Boston University School of Medicine, Boston, Massachusetts.

Adv Radiat Oncol ; 3(2): 181-189, 2018.

Article em En | MEDLINE | ID: mdl-29904743

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Revista: Adv Radiat Oncol Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google